Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,700 | 91,800 | 48,700 | 64,700 | 71,000 |
| Receivables | 970,000 | 893,500 | 860,600 | 946,200 | 966,800 |
| Inventories | 834,500 | 796,400 | 856,600 | 1,014,300 | 1,038,300 |
| Other current assets | 234,700 | 194,200 | 203,700 | 226,700 | 217,400 |
| TOTAL | $2,094,900 | $1,975,900 | $1,969,600 | $2,251,900 | $2,293,500 |
| Non-Current Assets | |||||
| PPE Net | 1,194,800 | 1,145,900 | 1,158,400 | 1,208,500 | 1,199,500 |
| Investments And Advances | 0 | 0 | 72,400 | 0 | 0 |
| Intangibles | 2,267,900 | 1,785,900 | 1,789,600 | 1,946,900 | 1,960,200 |
| Other Non-Current Assets | 417,800 | 373,200 | 280,500 | 344,100 | 362,600 |
| TOTAL | $3,880,500 | $3,305,000 | $3,300,900 | $3,499,500 | $3,522,300 |
| Total Assets | $5,975,400 | $5,280,900 | $5,270,500 | $5,751,400 | $5,815,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,100 | 1,200 | 1,400 | 1,300 | 6,400 |
| Accounts payable and accrued liabilities | 266,200 | 267,500 | 313,400 | 346,800 | 285,200 |
| Accrued Expenses | 555,000 | 475,700 | 552,500 | 555,100 | 483,700 |
| TOTAL | $1,632,400 | $1,178,500 | $1,228,000 | $1,721,500 | $1,707,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 974,800 | 950,000 | 950,300 | 951,200 | 951,300 |
| aiOther Non-Current Liabilities | 773,500 | 758,800 | 762,300 | 758,600 | 768,700 |
| TOTAL | $1,962,100 | $1,929,300 | $1,939,800 | $1,943,800 | $1,960,800 |
| Total Liabilities | $3,594,500 | $3,107,800 | $3,167,800 | $3,665,300 | $3,667,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,008 | 150,168 | 149,602 | 148,589 | 152,012 |
| Common Shares | 717,400 | 717,400 | 717,400 | 717,400 | 717,400 |
| Retained earnings | 4,363,300 | 4,204,300 | 4,157,700 | 4,028,600 | 4,010,100 |
| Other shareholders' equity | -113,900 | -134,000 | -122,600 | -89,200 | -106,600 |
| TOTAL | $2,380,900 | $2,173,100 | $2,102,700 | $2,086,100 | $2,147,900 |
| Total Liabilities And Equity | $5,975,400 | $5,280,900 | $5,270,500 | $5,751,400 | $5,815,800 |